Involvement of phospholipid signal transduction pathways in morphine tolerance in mice

British Journal of Pharmacology

Volumn 128, Issue 1, 1999, Pages 220-226

  Smith, Forrest L ^a   Lohmann, Alka B ^a   Dewey, William L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Inositol 1,4,5 trisphosphate; Morphine tolerance; Phosphatidylinositol cascade; Phospholipid metabolism; Protein kinase C

Indexed keywords

BISINDOLYLMALEIMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE; MORPHINE; OPIATE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPID; PHOSPHOTRANSFERASE; PLACEBO; SANGIVAMYCIN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG IMPLANTATION; DRUG PELLET; DRUG POTENCY; HOMEOSTASIS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0032859753     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702771     Document Type: Article

References (37)

1. Aston-Jones, G., Shipley, M.T., Chouvet, G., Ennis, M., Van Bockstaele, E., Pieribone, V., Shiekhattar, R., Akaoka, H., Drolet, G. & Astier, B. (1991). Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res., 88, 47-75.
2. Bernstein, M.A. & Welch, S.P. (1997). Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend., 44, 41-46.
3. Billah, M.M. & Anthes, J.C. (1990). The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J., 269, 281-291.
4. Bilsky, E.J., Bernstein, R.N., Wang, Z., Sadee, W. & Porreca, F. (1996). Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance. J. Pharmacol. Exp. Therap., 277, 484-490.
5. Bliss, C.I. (1967). Statistics in Biology, p. 439. New York: McGraw-Hill.
6. Colquhoun, D. (1971). Lectures in Biostatistics: An Introduction to Statistics With Applications in Biology and Medicine. London: Oxford Clarendon Press.
7. D'Amour, F.E. & Smith, D.L. (1941). A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
8. Dennis, E.A., Rhee, S.G., Billah, M.M. & Hannun, Y.A. (1991). Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J., 5, 2068-2077.
9. Dewey, W.L., Harris, L.S., Howes, J.F. & Nuite, J.A. (1970). The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther., 175, 435-442.
10. ++]i oscillations in bullfrog sympathetic neurons. Neuron, 8, 1109-1125.
11. ++ release of protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol., 300, 173-181.
12. Fundytus, M.E., Ritchie, J. & Coderre, T.J. (1997). Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br. J. Pharmacol., 120, 1015-1020.
13. Harris, L.S. & Pierson, A.K. (1964). Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther., 143, 141-148.
14. Hasbi, A., Polastron, J., Allouche, S., Stanasila, L., Massotte, D. & Jauzac, P. (1998). Desensitization of the delta-opioid receptor correlates with its phosphorylation in SK-N-BE cells: involvement of a G protein-coupled receptor kinase. J. Neurochem., 70, 2129-2138.
15. Helfman, D.M., Barnes, K.C., Kinkade, J.M., Vogler, W.R., Shoji, M. & Kuo, J.F. (1983). Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res., 43, 2955-2961.
16. Jonas, S., Sugimori, M. & Llinas, R. (1997). Low molecular weight heparin a neuroprotectant? Ann. N.Y. Acad. Sci., 825, 389-393.
17. Kunapuli, P., Onorato, J.J., Hosey, M.M. & Benovic, J.L. (1994). Expression, purification, and characterizatioan of the G protein-coupled receptor kinase GRK5. J. Biol. Chem., 269, 1099-1105.
18. Lauri, S.E., Kaukinen, S., Kinnunen, T., Ylinen, A., Imai, S., Kaila, K., Taira, T. & Rauvala, H. (1999). Regulatory role and molecular interactions of a cell-surface heparin sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J. Neurosci., 19, 1226-1235.
19. Malmberg, A.B., Chen, C., Tonegawa, S. & Basbaum, A.I. (1997). Preserved acute pain and reduced neuropathic pain in mice lacking PKC-γ. Science, 278, 279-283.
20. Mao, J., Price, D.D., Phillips, L.L., Lu, J. & Mayer, D.J. (1995). Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res., 677, 257-267.
21. Morikawa, H., Fukuda, K., Mima, H., Shoda, T., Kato, S. & Mori, K. (1998). Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells. Br. J. Pharmacol., 123, 1111-1118.
22. Narita, M., Makimura, M., Yangzheng, F., Hoskins, B. & Ho, I.K. (1994). Influence of chronic morphine treatment on protein kinase C activity comparison with butorphanol and implication for opioid tolerance. Brain Res., 650, 175-179.
23. Narita, M., Mizoguchi, H., Kampine, J.P. & Tseng, L.F. (1996). Role of protein kinase C in desentitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol., 118, 1829-1835.
24. Narita, M., Narita, M., Mizoguchi, H. & Tseng, L.F. (1995). Inhibition of protein kinase C, but not protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol., 280, R1-R3.
25. Narita, M., Ohsawa, M., Mizoguchi, H., Kamei, J. & Tseng, L.F. (1997). Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu-but not epsilon-opioid receptor agonist in the mouse. Neuroscience, 76, 291-298.
26. Ohsawa, M. & Kamei, J. (1997). Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5] enkephalin-induced antinociception in diabetic mice. Eur. J. Pharmacol., 339, 27-31.
27. Patrick, G.A., Dewey, W.L., Spaulding, T.C. & Harris, L.S. (1975). Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet-implanted mice. J. Pharmacol. Exp. Ther., 193, 876-883.
28. Pedigo, N.W., Dewey, W.L. & Harris, L.S. (1975). Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther., 193, 845-852.
29. Powis, G. & Phil, D. (1994). Inhibitors of phosphatidylinositol signalling as antiproliferative agents. Cancer Metastasis Rev., 13, 91-103.
30. Reichling, D.B, Kwiat, G.C. & Basbaum, A.I. (1988). Anatomy, physiology and pharmacology of the periaquiductal gray contribution to antinociceptive controls. In: Fields H.L. & Besson, J.M. (eds) Progress in Brain Research, pp. 31 -46. New York: Elsevier Science Publishers B.V. (Biomedical Division).
31. Smith, F.L., Dombrowski, D.S. & Dewey, W.L. (1999). Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol. Biochem. Behav., 62, 381-388.
32. Smith, F.L. & Stevens, D.L. (1995). Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J. Pharmacol. Exp. Ther., 272, 290-299.
33. Suaudeau, C., Florin, S., Meunier, J.C. & Costentin, J. (1998). Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam. Clin. Pharmacol., 12, 420-425.
34. Tallarida, R.J. & Murray, R.B. (1987). Manual of Pharmacologic Calculations with Computer Programs. Second Edition. pp. 26-44. New York: Springer-Verlag.
35. Ventayol, P., Busquets, X. & Garcia-Sevilla, J.A. (1997). Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 491-500.
36. Zhang, J., Ferguson, S.S., Barak, L.S., Bodduluri, S.R., Laporte, S.A., Law, P.Y. & Caron, M.G. (1998). Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U.S.A., 95, 7157-7162.
37. ++ in the analgesia induced by buprenorphine. Metal Ions Biol. Med., 2, 340-342.